Brett Kaplan - Insider Trading & Ownership

Entity
Individual
Location
C/O Prevail Therapeutics Inc., 430 East 29 Th Street, Suite 940, New York, NY
Summary
The estimated net worth of Brett Kaplan is at least $618K dollars as of August 26, 2024. Brett Kaplan is the Chief Operating Officer of Eliem Therapeutics, Inc. and owns shares of Climb Bio, Inc. (CLYM) stock worth about $618K.
All Insider Reports
All Insider Reports

Ownership of Brett Kaplan

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
CLYM Climb Bio, Inc. Chief Operating Officer $618K Aug 26, 2024
CMPX Compass Therapeutics, Inc. Director Feb 18, 2022

Insider Transactions Reported by Brett Kaplan:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.